<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="25">
  <stage>Registered</stage>
  <submitdate>13/07/2005</submitdate>
  <approvaldate>13/07/2005</approvaldate>
  <actrnumber>ACTRN12605000008628</actrnumber>
  <trial_identification>
    <studytitle>The Funhaler study</studytitle>
    <scientifictitle>A randomised controlled study evaluating the impact of a novel spacer, the Funhaler, on adherence and drug delivery in childhood asthma</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Childhood asthma</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Asthma</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>RCT comparing adherence, drug delivery and asthma control of 2-7 year old children with asthma using a Funhaler (Infamed) over a 4 month period.</interventions>
    <comparator>A control spacer (Aerochamber plus) overa 4 month period.</comparator>
    <control>Active</control>
    <interventioncode>None</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Adherence with daily preventive medication</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Drug delivery</outcome>
      <timepoint>Measured at enrolment and at the conclusion of the study using filters connected to the spacer.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Asthma control judged by questionnaire data.</outcome>
      <timepoint>At each visit and at the conclusion of the study.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Asthma, Currently on daily preventive medication.</inclusivecriteria>
    <inclusiveminage>2</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>7</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>No exclusion criteria</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Randomised sealed opaque envelopes. Blocled in random alloquots</concealment>
    <sequence>Computer generated. Blocked</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>7/05/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Scott Burgess</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>fellowsip grant from the Thoracic Society of Australia &amp; New Zealand</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>Nil</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Mater Children's Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Scott Burgess</name>
      <address>Department of Respiratory Medicine
Mater Hospital
Raymond Terrace QLD 4101</address>
      <phone>+61 7 38408111</phone>
      <fax>+61 7 38408366</fax>
      <email>sburgess@mater.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Scott Burgess</name>
      <address>Department of Respiratory Medicine 
Mater Hospital
Raymond Terrace QLD 4101</address>
      <phone>+61 7 38408111</phone>
      <fax>+61 7 38408366</fax>
      <email>sburgess@mater.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>